Back to SNY Stock Lookup
Pages: 1 2 »» Last Page

SNY Related Company Press Releases

May 23, 2013 07:00 AM Isis Pharmaceuticals to Present at the Deutsche Bank 38th Annual dbAccess Health Care Conference
May 21, 2013 04:00 PM Alnylam to Webcast Presentation at Deutsche Bank 38th Annual dbAccess Health Care Conference
May 21, 2013 08:15 AM Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
May 21, 2013 02:00 AM Sanofi Relies on Axway to Future-Proof their Infrastructure and Reduce Operational Costs through Global Consolidation
May 20, 2013 09:00 AM BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
May 17, 2013 08:00 AM Sanofi Reports Positive Topline Results from Pivotal Phase III JAKARTA Study for JAK2 Inhibitor in Myelofibrosis
May 17, 2013 08:00 AM Alnylam Presents Key Pre-Clinical Proof-of-Concept Data for ALN-AS1, an RNAi Therapeutic Targeting Aminolevulinate Synthase-1 (ALAS-1) for the Treatment of Porphyria
May 16, 2013 05:49 PM BioMarin Announces BMN-673 Data in Breast and Ovarian Cancers to be Released at ASCO
May 16, 2013 08:00 AM Football Legend Jerome Bettis & Sanofi US Tackle Anaphylaxis During National Asthma and Allergy Awareness Month
May 15, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 UBS Global Healthcare Conference
May 15, 2013 01:00 AM Sanofi and Regeneron Announce Patient Enrollment in Two Phase 3 Trials with Sarilumab in Rheumatoid Arthritis (RA)
May 14, 2013 09:00 AM BioMarin to Present at the UBS Global Healthcare Conference
May 14, 2013 07:00 AM Jack Green Joins Verastem as Chief Financial Officer
May 13, 2013 10:00 AM PatientsLikeMe and CISCRP Team up with Sanofi to Spotlight Medical Heroes and Clinical Trial Participation
May 13, 2013 07:00 AM Isis Pharmaceuticals to Present at the 2013 UBS Global Healthcare Conference
May 9, 2013 04:34 PM Isis Pharmaceuticals Earns $3.5 Million from Biogen Idec
May 9, 2013 04:06 PM NeoStem CEO's Letter to Shareholders
May 9, 2013 02:39 PM Isis Pharmaceuticals to Present at the Bank of America Merrill Lynch 2013 Health Care Conference
May 9, 2013 10:41 AM T2 Biosystems Named 2013 SBANE New England Innovation Award Winner
May 9, 2013 07:46 AM BG Medicine Appoints Dr. Paul Sohmer as Chief Executive Officer
May 8, 2013 09:50 PM Isis Pharmaceuticals Prices Public Offering Of Common Stock
May 8, 2013 04:00 PM Alnylam to Webcast Presentation at 2013 Bank of America Merrill Lynch Health Care Conference
May 7, 2013 04:08 PM Isis Pharmaceuticals Announces Proposed Public Offering of Common Stock
May 7, 2013 04:05 PM Isis Reports Financial Results and Highlights for First Quarter 2013
May 6, 2013 04:00 PM Alnylam Pharmaceuticals Reports First Quarter 2013 Financial Results
May 6, 2013 03:13 PM New Gold Bond® No Mess Powder Spray Introduced by Sanofi's Chattem
May 6, 2013 08:00 AM Sanofi US and Actress Elizabeth Perkins Premiere Documentary -- Diabetes Co-Stars Presents "Strength in Numbers"
May 6, 2013 07:00 AM Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
May 2, 2013 12:58 PM Webcast Alert: Isis Pharmaceuticals' First Quarter 2013 Financial Results Conference Call
May 2, 2013 09:00 AM BioMarin to Present at the Baird Growth Stock Conference
May 2, 2013 07:00 AM Sanofi: Q1 2013 business EPS(1) impacted by exclusivity losses in prior year
May 2, 2013 01:45 AM Sanofi Q1 2013 - Interview with CFO Jérôme Contamine
May 1, 2013 03:05 PM First Manhattan Files Preliminary Proxy Materials with SEC for the Election of Six Directors to Vivus’ Board at the 2013 Annual Meeting
May 1, 2013 07:30 AM ViroPharma Announces First Quarter 2013 Financial Results
Apr 30, 2013 09:07 AM Virginia Bio Recognizes Twenty Outstanding Contributions to Bioscience within the Commonwealth
Apr 30, 2013 08:00 AM NextBio Announces Translational Medicine Partnership with Sanofi
Apr 29, 2013 04:00 PM Alnylam to Webcast Conference Call Discussing First Quarter 2013 Financial Results
Apr 25, 2013 04:03 PM BioMarin Announces First Quarter 2013 Financial Results
Apr 25, 2013 09:24 AM Retrophin Names Horacio Plotkin, M.D. as Chief Medical Officer
Apr 25, 2013 08:00 AM Mall of America With Twentieth Century Fox Consumer Products and Global Experience Specialists to Host World Premiere of CAMP ICE AGE
Apr 25, 2013 01:00 AM Once-daily AUBAGIO® Delayed Onset of Clinically Definite Multiple Sclerosis (MS) in TOPIC Study
Apr 24, 2013 04:00 PM BioMarin Submits Vimizim MAA to EMA for the Treatment of MPS IVA
Apr 23, 2013 04:30 PM Alnylam to Webcast Presentation at 12th Annual Needham Healthcare Conference
Apr 23, 2013 08:00 AM U.S. FDA Grants Fast-Track Designation to Sanofi Pasteur and KaloBios' Novel Biologic Candidate for Pseudomonas aeruginosa
Apr 23, 2013 07:00 AM ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
Apr 23, 2013 12:01 AM Global Experience Specialists Partners with National Geographic on 'Earth Explorers' Exhibition
Apr 22, 2013 05:13 PM Isis Pharmaceuticals to Present at the 12th Annual Needham Healthcare Conference
Apr 18, 2013 09:00 AM BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Apr 18, 2013 08:00 AM Genzyme Convenes 13th European Fabry Disease Roundtable
Apr 17, 2013 10:00 AM DIA to Shine Light on Newly Released PCAST Report
Pages: 1 2 »» Last Page

Back to SNY Stock Lookup